Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

52.51
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
32.83
Today|||52-Week Range
53.49
+46.43%
Year-to-Date

Today’s Trading

Previous close52.51
Today’s open52.06
Day’s range52.02 - 52.65
Volume1,766,290
Average volume (3 months)1,853,878
Market cap$103.3B
Data as of 4:02pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+3.81%
P/E ratio21.5
Price/Sales5.48
Price/Book20.48

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co0.000.00%
ABTAbbott Laboratories0.000.00%
GSKGlaxoSmithKline0.000.00%
BMYBristol-Myers Squibb0.000.00%
Data as of 4:04pm ET, 12/15/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.56
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts